Quick answers
- What is Transderm Scop?
- Transderm Scop is a brand name of Scopolamine, a prescription medicine. The FDA NDC Directory lists 1 Transderm Scop product in 1 strength and form.
- Who makes Transderm Scop?
- Baxter Hlthcare Corp holds the FDA application for Transderm Scop (NDA017874, approved December 31, 1979).
- Is there a generic or store brand of Transderm Scop?
- Yes. The FDA NDC Directory lists 9 other products with the same active ingredients, strength and form as a Transderm Scop product, 9 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Transderm Scop?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Transderm Scop strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Transderm Scop been recalled?
- FDA enforcement reports list 1 recall of Transderm Scop products; the newest started April 13, 2022. A recall usually concerns specific lots, not every product.
What Transderm Scop is
Each Transderm Scop product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Scopolamine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| scopolamine 1 mg/3 d patch, extended release (transdermal) | Transderm Scop | 9 products, 6 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Scopolamine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA017874 | Baxter Hlthcare Corp | December 31, 1979 | 1 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| scopolamine 1 mg/3 d patch, extended release | Brand: Transderm Scop | $10.57 per patch Generic of the same strength and form: $4.22 per patch |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Transderm Scop
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Transderm Scop products.
- Baxter Healthcare Corporation1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
April 13, 2022 · Class II · Terminated · D-1083-2022
cGMP deviations: Temperature abuse
Transderm Scop (scopolamine) Transdermanl System, 1 mg/ 3 days, 10 (patches) transdermal Systems Multipack, Rx only, MFG: Baxter Healthcare Corp, NDC 10019-553-03 — Mckesson Medical-Surgical Inc. Corporate Office
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.